Effect of green tea and wheat bran on professional drivers with metabolic syndrome: A controlled clinical trial
An Erratum to this article was published on August 9, 2025. https://dergipark.org.tr/en/pub/tjph/article/1759365
Abstract
Objective: The present study aims to investigate the effect of Green Tea (GT) and Wheat Bran (WB) on Metabolic Syndrome in male drivers.
Methods: A controlled clinical trial was conducted with two intervention groups (GT and WB) and a control group on ninety male drivers with metabolic syndrome. Random allocation was done using permuted block randomization. Before the intervention, parametric measurements (height, weight, systolic and diastolic blood pressure, and abdominal circumference) and blood tests (fasting blood sugar (FBS), triglycerides (TG), high-density lipoprotein (HDL)) were checked. The GT group consumed three cups of GT tea bags (1gr) daily, and the WB group received 3.5 grams of WB powder daily. After two months, measurements and tests were repeated.
Results: There were no significant differences in blood pressure among the groups (p>0.05). The GT group showed a decrease in weight, FBS, and TG, as well as an increase in HDL. The WB group also exhibited a decrease in FBS and TG and an increase in HDL. A significant increase was found in the HDL level in the GT group before and after the intervention (p<0.05).
Conclusion: Consumption of green tea has been effective in reducing the number of patients with metabolic syndrome, and consumption of green tea and wheat bran can positively increase HDL. Also, green tea can be effective in reducing weight, FBS, and TG in male drivers suffering from metabolic syndrome.
Keywords
References
- Alauddin, M., et al., Fermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats. BMC Complement Altern Med, 2016. 16(1): p. 1-11.
- Kumari, R., S. Kumar, and R. Kant, An update on metabolic syndrome: Metabolic risk markers and adi-pokines in the de-velopment of metabolic syndrome. Diabetes Metab Syndr, 2019. 13(4): p. 2409-2417.
- Grundy, S.M., et al., Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 2004. 109(3): p. 433-438.
- Azizi, F., et al., Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract, 2003. 61(1): p. 29-37.
- Zhu, B., et al., Association between eating speed and metabolic syndrome in a three-year population-based cohort study. Int J Epidemiol, 2015. 25(4): p. 332-336.
- James, P.T., et al., The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Re-habil, 2004. 11(1): p. 3-8.
- Najafi, F., et al., Measuring and decomposing socioeconomic inequalities in adult obesity in Western Iran. J Prev Med Public Health, 2018. 51(6): p. 289.
- Tabrizi, J.S., et al., Prevalence and associated factors of overweight or obesity and abdominal obesity in Iranian popula-tion: a population-based study of northwestern Iran. Iranian journal of public health, 2018. 47(10): p. 1583.
- Chowdhury, A., et al., Protective role of epigallocatechin-3-gallate in health and disease: a perspec-tive. Biomed Pharma-cother, 2016. 78: p. 50-59.
- Janssens, P.L., R. Hursel, and M.S. Westerterp-Plantenga, Nutraceuticals for body-weight manage-ment: The role of green tea catechins. Physiol Behav, 2016. 162: p. 83-87.